Fidaxomicin Withdrawn Phase 4 Trials for Clostridium Difficile Infection (CDI) Prevention

IndicationsStatusPurposePhase
WithdrawnPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01552668Fidaxomicin to Prevent Clostridium Difficile Colonization